Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000315066-16-005625
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-18 14:00:38
Reporting Period:
2016-02-17
Filing Date:
2016-02-18
Accepted Time:
2016-02-18 14:00:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1445283 Proteostasis Therapeutics Inc. PTI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
315066 Fmr Llc 245 Summer Street
Boston MA 02210
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-02-17 925,051 $0.00 1,318,932 No 4 C Indirect F-Prime Capital Partners Healthcare Fund II LP
Common Stock Acquisiton 2016-02-17 183,880 $0.00 1,502,812 No 4 C Indirect F-Prime Capital Partners Healthcare Fund II LP
Common Stock Acquisiton 2016-02-17 375,000 $8.00 1,877,812 No 4 P Indirect F-Prime Capital Partners Healthcare Fund II LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect F-Prime Capital Partners Healthcare Fund II LP
No 4 C Indirect F-Prime Capital Partners Healthcare Fund II LP
No 4 P Indirect F-Prime Capital Partners Healthcare Fund II LP
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2016-02-17 10,000,000 $0.00 925,051 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2016-02-17 1,987,782 $0.00 183,880 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. On February 17, 2016, in connection with the completion of the issuer's initial public offering, all shares of Convertible Preferred Stock converted into shares of Common Stock at a 10.8102-for-one conversion ratio.
  2. Includes 393,881 shares of Common Stock issued as payment of accrued dividends upon conversion of the Series A Convertible Preferred Stock on February 17, 2016.